ELDN – eledon pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Eledon Pharmaceuticals (NASDAQ:ELDN) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Eledon Pharmaceuticals to Participate in the 37th Annual Piper Sandler Healthcare Conference [Yahoo! Finance]
Eledon Pharmaceuticals to Participate in the 37th Annual Piper Sandler Healthcare Conference
Eledon Reports Preliminary Data from First Six Patients with Type 1 Diabetes Treated with Tegoprubart as the Core Immunosuppressant Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine
Eledon Pharmaceuticals (NASDAQ:ELDN) had its price target lowered by analysts at Guggenheim from $9.00 to $8.00. They now have a "buy" rating on the stock.
Form SCHEDULE 13G Eledon Pharmaceuticals, Filed by: Coastlands Capital LP
Form 8-K Eledon Pharmaceuticals, For: Nov 14
Form 10-Q Eledon Pharmaceuticals, For: Sep 30
Form 8-K Eledon Pharmaceuticals, For: Nov 12
Form 424B5 Eledon Pharmaceuticals,
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.